William Freed-Pastor

5PUBLICATIONS
89CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 01, 2026
Insights on Future Directions in Cancer Research from the 2026 AACR NextGen Stars.

CheukMan Cherie Au, Daniel D Azorín, Jian Carrot-Zhang

|May 08, 2025
Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition.

Zackery A Ely, Zachary J Kulstad, Gurcan Gunaydin

|Sep 21, 2022
Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.

Andressa Dias Costa, Sara A Väyrynen, Akhil Chawla

|Jul 28, 2022
Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment.

William L Hwang, Karthik A Jagadeesh, Jimmy A Guo

|Jun 15, 2022
Deciphering the immunopeptidome in vivo reveals new tumour antigens.

Alex M Jaeger, Lauren E Stopfer, Ryuhjin Ahn

Pageof 1

Frequent Collaborators

3 joint publications

Tyler Jacks

2 joint publications

Andrew J Aguirre

2 joint publications

Brian M Wolpin

1 joint publications

Lauren E Stopfer